Reldesemtiv (CK2127107; CK-2127107; CK107; CK-107) is a novel, potent and second-generation fast skeletal muscle troponin activator (FSTA) with the potential for the Treatment of Impaired Muscle Function. It increases force production at submaximal stimulation frequencies. Reldesemtiv demonstrated increased muscle force generation in a phase 1 clinical trial and is currently being evaluated in clinical trials for the treatment of amyotrophic lateral sclerosis.

纯度：≥98%

CAS：1345410-31-2